Table 1.
Variable | Sub‐variable/category | Unit | All patients (N = 121) | |
---|---|---|---|---|
1 | Age (years) | Mean/SD | 58.7/10.9 | |
2 | Height | Mean/SD | 166.8/10.3 | |
3 | Weight | Mean/SD | 82.7/16.8 | |
4 | BMI | Mean/SD | 29.8/5.7 | |
5 | Pulse rate (beats/min) | Mean/SD | 73.6/9.3 | |
6 | Systolic blood pressure (mmHg) | Mean/SD | 135.6/14.9 | |
7 | Diastolic blood pressure (mmHg) | Mean/SD | 81.1/8.5 | |
8 | Respiratory rate (×/min) | Mean/SD | 16.1/4.2 | |
9 | Gender | Male | N/% | 77/63.6 |
Female | 44/36.4 | |||
10 | Concomitant disease | Yes | N/% | 96/79.3 |
No | 25/20.7 | |||
11 | Surgical and medical procedures | Yes | N/% | 69/57.0 |
No | 52/43.0 | |||
12 | Neurological signs for radiculopathy at examination | Yes | N/% | 30/24.8 |
No | 91/75.2 | |||
13 | Musculoskeletal signs at examination | Yes | N/% | 43/35.5 |
No | 78/64.5 | |||
14 | Pain Intensity Score (NRS‐3) | Mean/SD | 7.3/1.0 | |
15 | PainDETECT Questionnaire Score | Mean/SD | 15.5/7.6 | |
16 | PDQ‐Items | BUR | Mean/SD | 2.0/1.7 |
17 | PRI | Mean/SD | 2.1/1.7 | |
18 | ALD | Mean/SD | 1.3/1.5 | |
19 | ATT | Mean/SD | 2.7/1.5 | |
20 | TER | Mean/SD | 1.4/1.5 | |
21 | NMB | Mean/SD | 2.0/1.7 | |
22 | PRS | Mean/SD | 2.4/1.5 | |
23 | PDQ (categories) | Unlikely | N/% | 41/36.0 |
Unclear | 30/26.3 | |||
Likely | 43/37.7 | |||
24 | PDQ–Cluster1 | Yes | N/% | 18/15.4 |
No | 99/84.6 | |||
25 | PDQ–Cluster2 | Yes | N/% | 23/19.7 |
No | 94/80.3 | |||
26 | PDQ–Cluster3 | Yes | N/% | 24/20.5 |
No | 93/79.5 | |||
27 | PDQ–Cluster4 | Yes | N/% | 36/30.8 |
No | 81/69.2 | |||
28 | PDQ–Cluster5 | Yes | N/% | 16/13.7 |
No | 101/86.3 | |||
29 | Subject's satisfaction with treatment | Mean/SD | 0.6/0.5 | |
30 | HADS‐Depression Scale | Mean/SD | 7.4/4.4 | |
31 | HADS‐Anxiety Scale | Mean/SD | 7.4/4.3 | |
32 | SQ‐Sleep Quality Score | Mean/SD | 2.8/0.8 | |
33 | SQ‐Wake up | Mean/SD | 2.8/1.8 | |
34 | SQ‐Sleep last night | Mean/SD | 362.1/100.4 | |
35 | SQ‐Bedtime last night | Mean/SD | 5.9/3.3 | |
36 | SF36 – Physical Functioning | Mean/SD | 37.9/21.4 | |
37 | SF36 – Role Physical | Mean/SD | 22.5/35.7 | |
38 | SF36 – Bodily Pain | Mean/SD | 27.6/15.6 | |
39 | SF36 – General Health | Mean/SD | 45.7/18.4 | |
40 | SF36 – Vitality | Mean/SD | 38.9/20.6 | |
41 | SF36 – Social Functioning | Mean/SD | 57.3/28.9 | |
42 | SF36 – Role Emotional | Mean/SD | 46.8/46.4 | |
43 | SF36 – Mental Health | Mean/SD | 55.8/20.5 | |
44 | SF36 PCS | Mean/SD | 32.5/7.7 | |
45 | SF36 MCS | Mean/SD | 42.0/12.3 | |
46 | EQ5D‐VAS | Mean/SD | 51.9/20.5 |
NRS‐3, Pain Intensity Score in the last three days; SQ, Sleep Evaluation Questionnaire; SF 36, Short Form 36 Health Survey; EQ5D VAS, EuroQol‐Health State Today; HADS, Hospital Anxiety and Depression Scale; PDQ, painDETECT questionnaire; PD‐Q clusters, subgroups of patients based on different painDETECT symptom profiles according to Förster et al. (2013) and Baron et al. (2012).
Patients who had available baseline data and who started with a titration of the treatment and could be followed up during the titration and maintenance period of the trial.